Business Context and Reporting Period
Community Health Systems, Inc. filed this Form 8-K on February 20, 2002, to announce operating results for the fourth quarter and full year ended December 31, 2001. The filing also provides forward-looking guidance for the fiscal year ending December 31, 2002.
Key Financial Metrics and Guidance
The filing does not provide specific historical financial results for 2001 (revenue, profit, cash flow, or margins) within the text of the 8-K; these are contained in the attached press release (Exhibit 99.1). However, the document provides detailed projections for 2002:
| Metric | 2002 Projection Range |
|---|---|
| Net Operating Revenue | $2,050 million to $2,100 million |
| EBITDA | $358 million to $365 million |
| Net Income Per Share (Diluted) | $0.88 to $0.94 |
| Same Hospital Admissions Growth | 3.0% to 4.0% |
| Routine Capital Expenditures | $70 million to $75 million |
| Replacement Hospital Expenditures | $32 million to $35 million |
| Planned Acquisitions | 3 to 4 new hospitals |
| Weighted Average Diluted Shares | 102 million |
Quarterly EPS Estimates for 2002:
- Q1 (ending March 31): $0.24 to $0.25
- Q2 (ending June 30): $0.19 to $0.20
- Q3 (ending September 30): $0.20 to $0.22
- Q4 (ending December 31): $0.25 to $0.27
Material Changes and Accounting Adjustments
Effective January 1, 2002, the Company adopted SFAS No. 141 ("Business Combinations") and SFAS No. 142 ("Goodwill and Other Intangible Assets").
- Impact on Guidance: The 2002 financial guidance excludes non-cash amortization of goodwill but includes non-cash amortization of other intangibles.
- EPS Impact: This change results in an approximate reduction in goodwill amortization expense of $0.24 per share (after tax) for 2002.
- Impairment: No impairment write-down is expected from the adoption of these standards.
Outlook, Risks, and Unusual Items
Interest Rate Management: On November 20, 2001, the Company entered into three interest rate swap agreements (total notional amount of $300 million) to hedge against interest rate fluctuations on long-term borrowings. The Company pays fixed rates ranging from 3.37% to 4.46% and receives variable rates based on LIBOR.
Risk Factors: The Company cautions that actual results may differ materially from projections due to various factors, including:
- General economic conditions and demographic changes.
- Governmental regulations, compliance agreements, and healthcare reform proposals.
- Changes in Medicare and Medicaid payment levels.
- Uncertainty regarding HIPAA regulations.
- Liability claims and competition.
- Ability to attract qualified personnel and integrate acquisitions.
- Availability of capital for acquisitions and facility replacements.
Investor Verification Checklist
- Historical Results: Verify the actual Q4 and full-year 2001 operating results in the attached press release (Exhibit 99.1), as specific numbers are not listed in the 8-K text.
- Accounting Impact: Confirm the exact dollar value of the $0.24 per share benefit from the SFAS 141/142 adoption in the full financial statements.
- Debt Structure: Review the full debt schedule to understand the specific borrowings hedged by the $300 million in interest rate swaps.
- Acquisition Pipeline: Monitor the status of the planned 3 to 4 hospital acquisitions and associated capital requirements.